Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

February 01, 2010 (Vol. 30, No. 3)

Innovative Drug R&D on the Rise in China

Technically Savvy Returnees, Influx of VC Funding, and Solid Government Support Buoy Efforts

  • As the Chinese pharmaceutical industry expands rapidly, Chinese pharma and biotech companies—and even outsourcing service providers—are increasingly paying attention to and investing in innovative drug R&D. A flotilla of returnees and venture capital firms are aiding in these endeavors. Unfortunately, innovative R&D activities in China remain largely unknown ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.